All News

The FDA has issued draft guidances that should ease the way for more generic drugs.

A judge tossed an award given to a woman claiming baby powder caused ovarian cancer.

Will Shingrix become the new go-to shingles vaccine?

The chain has entered into a 5-year agreement with Anthem’s IngenioRx.

Young people with diabetes may do better with insulin pumps than they do with injections.

Diabetes patients are making fatal errors with their insulin pens-pharmacists can help.

The investigation is causing far-reaching ripples around the country, but how does it affect pharmacists?

Why it's a good time to become more involved in diabetes education.

IV compounding software can help reduce errors and increase patient safety.

A new NCPA report highlights the role of community pharmacies.

The use of the HPV vaccine may be creating herd immunity, protecting unvaccinated women.

Measles is still very rare in the United States, but most cases involved either someone who was not vaccinated or whose status is unknown.

NCPA CEO B. Douglas Hoey, RPh, MBA, discusses the problems and opportunities facing independent pharmacies.

Pharmacists can help patients-but only the ones they have time to reach.

Why are Americans shouldering the burden of paying for drug innovations?

A new ally in building up independent pharmacies.

Two groups are joining forces to enhance medication management.

What you (and your patients) need to know about flu vaccines this year.

What you need to know when filling prescriptions for Fido and Fluffy.

Vanderbilt Specialty Pharmacy has created a model to integrate its pharmacists into its specialty clinics.

The twice-annual event will feature a new incentive this October.

Edaravone has been approved for patients with amyotropic lateral sclerosis.

Antimicrobial susceptibility testing (AST) for newer antibiotics is falling behind because there is a lag time between FDA approval and inclusion in commercial AST devices.

High-alert drugs pose a significant threat to patient safety. There are safeguards that pharmacists should put in place to reduce the risk.

Dual antithrombotic therapy using dabigatran significantly reduces risk of bleeding compared to triple therapy using warfarin.

The risk of intraocular bleeding was reduced by one-fifth when using newer anticoagulants versus warfarin in a new study.

What you need to know about the upcoming NCPA convention.

Pharmacists are uniquely poised to combat the opioid crisis. Here's what pharmacists (and Congress) can do about it.